Skip to content
Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

Canopy Growth is a global leader in the cannabis industry, specializing in the production, distribution, and sale of a diverse portfolio of cannabis and cannabis-related products for both medical and adult-use markets.

Market cap
$411.14M+84.9%
Revenue$284.6M+5.8%
Net income-$262.9M+48.3%
Free cash flow-$69.1M+60.8%
EPS (diluted)-$1.31+84.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 7, 2026 (In 3 weeks)
Revenue estimate$58.2M
EPS estimate-$0.04

Financials

Q4 2026

Income statement

See full
Revenue$71.2M+9.6%
Gross profit$8.3M-21.7%
Operating income-$95.8M-424%
Net income-$154.7M+21.0%
EPS (diluted)-$0.88+81.4%

Balance sheet

See full
Cash & equivalents$364.7M+220%
Total debt$278.7M-20.0%
Total equity$697.6M+45.8%
Total assets$1.1B+21.9%

Cash flow

See full
Operating cash flow-$18.3M+44.9%
CapEx$1.0M-67.6%
Free cash flow-$19.3M+46.9%

Valuation & ratios

Valuation

See full
Market cap$411.14M+84.9%
Enterprise value$325.17M-17.3%
P/S1.4×+0.6×

Profitability

See full
Gross margin24.5%-5.1pp
Operating margin-56.8%+24.8pp
Net margin-92.4%-31.3pp
FCF margin-24.3%-9.4pp

Returns & leverage

See full
Return on equity-44.7%-17.0pp
Debt / equity0.4×-0.3×
Current ratio3.3×+0.5×

Segments

By product

See full
Canadian Medical Cannabis$25.3M+26.6%
Canadian Adult Use Cannabis$20.6M+0.9%
Storz Bickel$16.8M-14.0%
International Markets Cannabis$8.6M+67.6%

By segment

See full
Cannabis$53.5M
Storz And Bickel$16.8M-14.0%

Competitors

Profile

Canopy Growth is a global leader in the cannabis industry, specializing in the production, distribution, and sale of a diverse portfolio of cannabis and cannabis-related products for both medical and adult-use markets. The company operates an asset-right model focused on high-quality cultivation, innovation in delivery technologies, and the development of category-defining consumer brands. Its core value proposition centers on bettering lives through principled, consumer-centric cannabis solutions across North America, Europe, and Australia.

Competitive position

A leading global cannabis company with the top medical cannabis provider position in Canada and a dominant global position in the premium vaporization market through Storz & Bickel.

GeographiesCanada, Germany, United States, Australia, Poland, United Kingdom
Customer segmentsMedical Patients, Retail Consumers, Government Agencies
Business modelManufacturing, Wholesale, Direct-to-Patient, E-commerce
SuppliersThird-party raw material suppliers, Genetics and seed providers, Third-party manufacturers for vapes and edibles, Energy and utility providers for cultivation
CustomersProvincial and territorial cannabis control authorities, Medical cannabis patients, Retail cannabis stores, Healthcare practitioners, Veterans Affairs Canada
CountryCanada
Listed2014
Employees1.0K
CEOLuc Mongeau
FilingsSEC EDGAR

Questions, answered.

What is Canopy Growth Corporation's market cap?
Canopy Growth Corporation (CGC) has a market capitalization of $411.1M and trades on NASDAQ.
What is Canopy Growth Corporation's revenue and profitability?
Canopy Growth Corporation generated $284.6M in trailing twelve-month revenue with a net loss of $262.9M, representing a net margin of -92.4%. Gross margin stands at 24.5%, with free cash flow of -$69.1M. These figures are based on the Q1 2026 filing.
Who are Canopy Growth Corporation's competitors?
Canopy Growth Corporation's key competitors include Cronos Group Inc., Tilray Brands, Inc., Aurora Cannabis Inc., and others. These companies compete in similar markets and product categories.
Who does Canopy Growth Corporation partner with?
Canopy Growth Corporation's notable partners include Canopy USA, TerrAscend Corp., BMO Capital Markets, and others.
What subsidiaries does Canopy Growth Corporation have?
Canopy Growth Corporation's subsidiaries include Storz & Bickel GmbH, MTL Cannabis Corp., Apollo Cannabis Clinics, and others.
Where is Canopy Growth Corporation headquartered?
Canopy Growth Corporation is headquartered in Canada and employs approximately 1,029 people. It has been publicly traded since 2014.